It’s that time of year again! IDWeek 2023 is here and many of ARLG’s top leaders and experts are featured, discussing the latest AR topics. Whether you plan to attend virtually or in person, use the tables below to plan ahead to join your favorite sessions and posters.
Don’t miss Sara Cosgrove, MD, ARLG member and Director of the Johns Hopkins Hospital Department of Antimicrobial Stewardship Program, as the SHEA Lectureship featured speaker Oct. 13 from 4:45 – 6:00 p.m.
Learn more and view OnDemand content at IDWeek.org
IDWeek 2023 ARLG Sessions
| Day | Time | Session Title | Presentation Title | Moderators | Speakers |
|---|---|---|---|---|---|
| Oct. 11 | 10:15 am - 12:00 pm | PW04 - Fellows' Day Workshop | Infectious Diseases Careers in Research | Cesar Arias | |
| Oct. 11 | 1:30 - 3:15 pm | 6 – Mano-a-Mano | Latania Logan | ||
| Oct. 12 | 8:00 – 9:00 am | 14- Just Your Average Day in a Pediatric ID Clinic | Latania Logan | ||
| Oct. 12 | 8:00 – 9:00 am | 17- Optimizing Antibiotic Dosing in Children: From Monitoring to Management | Manjunath (Amit) Pai, Gauri Rao | ||
| Oct. 12 | 10:55 – 11:20 am | 21- Compendium Controversies | The Cutting Edge of Surgical Site Infection (SSI) Prevention: Highlights From the 2023 SSI Compendium | Keith Kaye | |
| Oct. 12 | 10:30 – 11:45 am | 28- Treatment Conundrums: Not Always Black and White | Pranita Tamma | ||
| Oct. 12 | 10:30 – 11:45 am | 30- Challenging Cases in Infectious Diseases | Thomas Holland (panelist) | ||
| Oct. 12 | 10:30 – 11:45 am | 32 – Diagnostic and Related ASP | Ryan Shields | ||
| Oct. 12 | 10:30 – 11:45 am | 33- Pediatric Bacterial Infections | Stephanie Fritz, Latania Logan | ||
| Oct. 12 | 12:15 – 12:45 pm | 38- Bench to Bedside: Basic Science in Resistance Mechanisms | Pranita Tamma | ||
| Oct. 12 | 1:45-3:00 pm | 66- Climate Change Is a Pandemic: Decreasing Emissions Is the Vaccine We Need to Be Part of the Solution | Latania Logan | ||
| Oct. 12 | 1:45-2:10 pm | 67- Clinical Trials That May Change Your Practice | Clinical Trials in Bacterial Diseases That May Change Your Practice | Thomas Holland | |
| Oct. 12 | 1:45-3:00 pm | 76- Complicated Bloodstream Infections & Endocarditis | Vance Fowler | ||
| Oct. 12 | 3:15-4:30 pm | 86- Wastewater Analysis: From Surveillance to Discovery | Patricia (Trish) Simner | ||
| Oct. 12 | 3:15-4:30 pm | 91- Addressing ASP in Special Populations | Ritu Banerjee | ||
| Oct. 13 | 8:00 –9:00 am | 98- New ID Diagnostics in the Pipeline | Angela Caliendo, Patricia (Trish) Simner | ||
| Oct. 13 | 8:00 –9:00 am | 106 – Linezolid Dosing: Can Less Be More? | Yohei Doi | ||
| Oct. 13 | 8:00 –9:00 am | 107 – Stewarding the Use of Novel Beta-Lactam Antibiotics | Pranita Tamma, Amy Mathers | ||
| Oct. 13 | 8:00 –8:30 am | 107 – Stewarding the Use of Novel Beta-Lactam Antibiotics | How Do I Decide Which Novel Beta-Lactam Agents I Need on My Hospital Formulary? | Ryan Shields | |
| Oct. 13 | 8:30 –9:00 am | 107 – Stewarding the Use of Novel Beta-Lactam Antibiotics | How Do I Determine the Likely Antibiotic Resistance Mechanisms Based on the Antibiotic Susceptibility Profile, any Why Should I Care? | Michael Satlin | |
| Oct. 13 | 10:30-11:45 am | 114 – Meet Me in the Metaverse: AI in ID | Lilian Abbo | ||
| Oct. 13 | 11:20-11:45 am | 114 – Meet Me in the Metaverse: AI in ID | Design Thinking, Applying AI in ID Locally and in Global Health | Larissa May | |
| Oct. 13 | 10:55-11:20 am | 115 – Microbiome Therapeutics: Leaving the Bench and Arriving at the Bedside | The Commercial Development of Human Derived Intestinal Microbiota for Prevention of Recurrent C. difficile Infection | Michael Woodworth | |
| Oct. 13 | 10:30 – 11:45 am | 124- Treatment of Challenging Gram-Negative Infections | Manjunath (Amit) Pai | ||
| Oct. 13 | 12:15 -12:45 pm | 125- Genitourinary Infections | Sonali Advani | ||
| Oct. 13 | 12:15 -12:45 pm | 128 – HAI, MDRO and C. diff | Anthony Harris | ||
| Oct. 13 | 1:45-3:00 pm | 175- C. diff, C. auris, MDROs, Oh My | Lilian Abbo, David van Duin | ||
| Oct. 13 | 3:15-3:40 pm | 183 - Influential Publications in Health Care Epidemiology, Antimicrobial Stewardship and Public Health | Influential Publications in Infection Prevention From the Past Year | Anthony Harris | |
| Oct. 13 | 3:15-4:30 pm | 184- Modernizing Antiviral Dosing Strategies | Manjunath (Amit) Pai | ||
| Oct. 13 | 5:30-6:00 pm | 194 – SHEA Lectureship | Notes From the Field: 20 Years of Progress in Antibiotic Stewardship | Sara Cosgrove | |
| Oct. 14 | 8:00 -9:00 am | 204- QI Tools to Support Your AMS Program | Pranita Tamma | ||
| Oct. 14 | 8:00 -9:00 am | 206- Tracking and Containing Antimicrobial-Resistant Health Care-Associated Infections With Novel Sequencing Approaches | Patricia (Trish) Simner | ||
| Oct. 14 | 10:30-11:45 am | 208-Beyond the 101: Pondering Perplexing Prescribing Issues | Pranita Tamma, Amy Mathers | ||
| Oct. 14 | 10:55-11:20 am | 210 – Effects of Antibiotics on Bacterial Virulence | Confluence of Resistance and Virulence in Klebsiella pneumoniae | David van Duin | |
| Oct. 14 | 10:30-11:45 am | 217 – What Is the Optimal Therapy for My Patient With Bacteremia? | Robert Bonomo, Sara Cosgrove (Interactive Moderators) | ||
| Oct. 14 | 10:30-11:45 am | 220 – Novel Surveillance Approaches for HAIs and MDROs | Anthony Harris | ||
| Oct. 14 | 1:45 – 3:00 pm | 256 – Reviving the Antimicrobial Pipeline: Costs, Challenges and Opportunities | Yohei Doi | ||
| Oct. 14 | 1:45 – 3:00 pm | 258 – What’s New in Head and Neck Infections | Latania Logan | ||
| Oct. 14 | 1:45-3:00 pm | 259 – Diagnostic Clinical Cases: What Do I Do With This Test Result? | Amy Mathers, Lars Westblade (Panelists) | ||
| Oct. 14 | 3:15 – 4:30 pm | 269 – Lab-Developed Tests: Critical, But Are They “Valid”? | Patricia (Trish) Simner | ||
| Oct. 14 | 3:15 – 4:30 pm | 278 – Microbiome & Biomarkers | Anne-Catrin Uhlemann |
IDWeek 2023 ARLG Posters
| Day, Time (EDT) | Number and Title | Authors |
|---|---|---|
| Oct. 12 3:15-3:27 pm | 1029 Increased Mortality in Hospital-Onset Carbapenem-Resistant Enterobacterales Bloodstream Infections | Presenting Author: Natalie Mackow Authors: Boutzoukas AE, Komarow L, Mackow N, Biri A, Hill C, Chen L, Doi Y, Satlin M, Arias C, Wang M, Yu Y, Mora L, Herc E, Cober E, Weston G, Alenazi T, Fowler V, van Duin D |
| Oct. 13 12:15-12:20 pm | 1115 Risk Factors for Recurrence of Community-Onset Urinary Tract Infections Caused by Extended Spectrum Cephalosporin-Resistant Enterobacterales | Presenting Author: Helen Zhang Authors: Zhang HL, Perez R, Krishnan J, Lautenbach E, Anderson DJ |
| Oct. 12 12:15-1:30 pm | 857 Impact of Rapid Antibiotic Susceptibility Testing for Gram Negative Bacteremia Varies by Pathogen Type and Resistance: A Secondary Analysis of the RAPIDS GN Trial | Banerjee R, Giri A, Komarow L, Souli M, Doernberg S, Patel R, for the Antibacterial Resistance Leadership Group |
| Oct. 12 12:15-1:30 pm | 369 The DOOR Is Open: A Web-based Application for Analyzing the Desirability of Outcome Ranking | Hamasaki T, He Y, Evans S |